ELIZABETH MARICLE: Open Payments
NPI 1396269668 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,099 in 144 payments from 24 companies in 2025. Trend: 2023 $260 · 2024 $1,333 · 2025 $3,099
Food & beverage: $2,653Education: $446
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $625 |
| AstraZeneca Pharmaceuticals LP | 12 | $331 |
| Novartis Pharmaceuticals Corporation | 14 | $267 |
| Astellas Pharma US Inc | 7 | $210 |
| ABBVIE INC. | 7 | $196 |
| Merck Sharp & Dohme LLC | 10 | $195 |
| E.R. Squibb & Sons, L.L.C. | 6 | $127 |
| EMD Serono, Inc. | 5 | $111 |
| Gilead Sciences, Inc. | 6 | $109 |
| Incyte Corporation | 6 | $109 |
Products named: LYNPARZA, DARZALEX, VENCLEXTA, ERLEADA, Fabhalta, TECVAYLI, KEYTRUDA, Vyloy.
Industry payments across IL — which companies pay providers there.
